Cargando…
Prognostic and predictive value of radiomics signatures in stage I‐III colon cancer
Accurate identification of patients with poor prognosis after radical surgery is essential for clinical management of colon cancer. Thus, we aimed to develop death and relapse specific radiomics signatures to individually estimate overall survival (OS) and relapse free survival (RFS) of colon cancer...
Autores principales: | Dai, Weixing, Mo, Shaobo, Han, Lingyu, Xiang, Wenqiang, Li, Menglei, Wang, Renjie, Tong, Tong, Cai, Guoxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240849/ https://www.ncbi.nlm.nih.gov/pubmed/32508036 http://dx.doi.org/10.1002/ctm2.31 |
Ejemplares similares
-
Prognostic nomograms for predicting cause-specific survival and overall survival of stage I–III colon cancer patients: a large population-based study
por: Zhou, Zheng, et al.
Publicado: (2019) -
Comprehensive Transcriptomic Analysis Reveals Prognostic Value of an EMT-Related Gene Signature in Colorectal Cancer
por: Mo, Shaobo, et al.
Publicado: (2021) -
A robust gene signature for the prediction of early relapse in stage I–III colon cancer
por: Dai, Weixing, et al.
Publicado: (2018) -
Hematopoietic Gene Expression Regulation Through m(6)A Methylation Predicts Prognosis in Stage III Colorectal Cancer
por: Zhou, Zheng, et al.
Publicado: (2020) -
Development and Validation of an Autophagy Score Signature for the Prediction of Post-operative Survival in Colorectal Cancer
por: Zhou, Zheng, et al.
Publicado: (2019)